# Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer

Source: https://onco.cc/trials/nct07764653/  
OnCo record `nct07764653` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Technetium Tc-99m sulfur colloid in Breast cancer, run by HTA Co., Ltd., completed.

## Summary

Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer is a phase 3 interventional study registered as NCT07764653 by HTA Co., Ltd., with 213 participants recorded, started 2024-01-02 and reaching its primary completion in 2025-06-03. Interventions recorded: Technetium Tc 99m Sulfur Colloid Injection, Mitoxantrone Hydrochloride Injection for Tracing. Conditions recorded: Sentinel Nodes, Breast Cancer.

Linked to the drug Technetium Tc-99m sulfur colloid because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07764653
- Phase: 3
- Setting: Efficacy and Safety of Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial
- Sponsor: HTA Co., Ltd.
- Enrolled: 213

## Sources

- ClinicalTrials.gov NCT07764653: https://clinicaltrials.gov/study/NCT07764653

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- drugs: [Technetium Tc-99m sulfur colloid](https://onco.cc/drugs/technetium-sulfur-colloid/)

---
JSON: https://onco.cc/api/v1/entities/nct07764653.json